Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 373

Results For "pharma"

3962 News Found

Sanofi buys Kadmon to grow its transplant business
Biotech | September 08, 2021

Sanofi buys Kadmon to grow its transplant business

It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)


ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant
Biotech | September 07, 2021

ABB’s ACS360 Drives enhance safety and energy efficiency at Bharat Biotech’s Covaxin plant

ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency


Brinton launches Hohner Health in India
Healthcare | September 06, 2021

Brinton launches Hohner Health in India

The focus is on wellness and personal care products


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month


Accutest enables NMPA approval for Qilu’s Abiraterone
Drug Approval | September 06, 2021

Accutest enables NMPA approval for Qilu’s Abiraterone

The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India


Alembic JV Aleor receives US FDA final approval for skin disorder gel
Drug Approval | September 06, 2021

Alembic JV Aleor receives US FDA final approval for skin disorder gel

Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea


Govt revises NLEM and slashes prices of 39 drugs
Policy | September 04, 2021

Govt revises NLEM and slashes prices of 39 drugs

At present 18 per cent of the local pharmaceutical market is under government's price control


Reliance Strategic Business Ventures acquires Strand Life Sciences for Rs 393 crores
Drug Approval | September 04, 2021

Reliance Strategic Business Ventures acquires Strand Life Sciences for Rs 393 crores

The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India


Reliance Life Science gets go-ahead for Phase I clinical trial for Covid-19 vaccine
Drug Approval | September 04, 2021

Reliance Life Science gets go-ahead for Phase I clinical trial for Covid-19 vaccine

The trial will be conducted across eight sites in Maharashtra


Indian Railways to deploy HMIS across its network
Digitisation | September 04, 2021

Indian Railways to deploy HMIS across its network

Implementation of the system to provide faster, seamless and hassle-free healthcare solutions